Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Squamous Cell × Radiotherapy, Intensity-Modulated × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 20 Oropharyngeal Neoplasms 16 Prostatic Neoplasms 11 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 9 Laryngeal Neoplasms 8 Rectal Neoplasms 7 Mouth Neoplasms 7 Head and Neck Neoplasms 7 Hypopharyngeal Neoplasms 6 Carcinoma, Squamous Cell 6 Carcinoma 6 Breast Neoplasms 6 Glioma 5 Glioblastoma 5 Esophageal Neoplasms 5 Uterine Cervical Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lung Neoplasms 4 Astrocytoma 4 Papillomavirus Infections 3 Nasopharyngeal Neoplasms 3 Lymphatic Metastasis 3 Leukemia, Myeloid, Acute 3 Endometrial Neoplasms 3 Anus Neoplasms 3 Thyroid Carcinoma, Anaplastic 2 Sarcoma 2 Pancreatic Neoplasms 2 Pancreatic Adenocarcinoma 2

Interventions

Nivolumab 3 pembrolizumab 2 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 abemaciclib 1 Taxes 1 Risk Factors 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 High-Intensity Focused Ultrasound Ablation 1 Erlotinib Hydrochloride 1 Docetaxel 1 Cyclophosphamide 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡